Últimos Artículos de Diabetes, Obesity and Metabolism
- Effectiveness of add‐on therapy with SGLT2 inhibitors or GLP‐1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study
- Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes
- The impact of novel probiotics isolated from the human gut on the gut microbiota and health
- Anti‐diabetic effects of GLP‐1 receptor agonists on obese and overweight patients across diabetes status, administration routes, treatment duration and baseline characteristics: A systematic review
- Aerobic exercise improves energy and glucose homeostasis through hypothalamic Mitofusion 2‐rescued endoplasmic reticulum stress in diet‐induced obese mice
- Minimum expectations for market authorization of continuous glucose monitoring devices in Europe—‘eCGM’ compliance status
- Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study
- Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase‐4 inhibitor plus low‐dose metformin: A multicenter, prospective, randomized, open‐label, parallel‐group comparison study (MEGMI study)
- Efficacy of imeglimin in patients with type 2 diabetes mellitus complicated by metabolic dysfunction‐associated steatotic liver disease: A multicentre study
- Exclusion of older persons from randomized controlled trials in type 2 diabetes: A cross‐sectional study
- Targeting central pathway of Glucose‐Dependent Insulinotropic Polypeptide, Glucagon and Glucagon‐like Peptide‐1 for metabolic regulation in obesity and type 2 diabetes
- Assessing the benefit–risk profile of newer glucose‐lowering drugs: A systematic review and network meta‐analysis of randomized outcome trials
- Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial
- Reply to the Letters by Louie and Pereira et al.
- Evaluation of the efficacy and safety of controlled‐release phentermine/topiramate in adults with obesity in Korea: A randomized, double‐blind, placebo‐controlled, phase 4 trial (QUEEN's study)
- Diagnostic accuracy of Agile‐4 score for liver cirrhosis in patients with metabolic dysfunction‐associated steatotic liver disease. A systematic review and meta‐analysis of diagnostic test accuracy studies
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial
- When can weekly anti‐obesity peptides be used for monthly administration?
- Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases
- Improved glycaemic control in people with type 2 diabetes initiating or switching to IDegAsp in a real‐world setting in China